
Dyne Therapeutics, Inc. (DYN) Dividend History
Dyne Therapeutics, Inc. is a biotechnology company focused on developing targeted delivery therapies for serious muscle diseases. Utilizing its proprietary DARPin® platform, Dyne designs molecules to deliver therapeutics precisely to muscle tissues, aiming to improve treatment outcomes for conditions such as Duchenne muscular dystrophy and other genetic muscle disorders.
Dividend History
Dyne Therapeutics, Inc. currently does not pay dividends
Company News
-
GlobeNewswire Inc.